Effects of Mulberry Leaf Extract Formulation on Postprandial Glycemic Levels in Obese Children and Adolescents

Enrolling by invitation · Not applicable · Has a placebo group

Conditions studied: Obesity

In brief

The study entitled "Effects of mulberry leaf extract formulationon Postprandial Glycemic Peak in Obese Children and Adolescents: A Pilot Study" aims to evaluate the improvement in glycemic and insulinemic levels produced by a food supplement extracted from white mulberry (Morus alba), after 12 weeks of treatment in a cohort of obese children and adolescents. Clinical and anthropometric data (age, sex, weight, height, BMI, pubertal stage) will be collected, along with data from blood chemistry tests performed during routine follow-up visits, in accordance with Good Clinical Practice guidelines.

Key facts

Study ID

NCT07494253

Run by

University of Bari Aldo Moro

People needed

80

Starts

2025-06-01

Expected to finish

2026-06-30

Last updated by the study team

2026-06-22

Who can join

Age: 6 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Body mass index (BMI) >95° percentile for age and sex, according to WHO growth standards
• absence of chronic deseases

You may not qualify if…

• diagnosis of type 1 diabetes
• chronic use of steroid drugs
• known allergies or hypersensitvity to any component of the stusy product (Reducose)
• use of medications known to affect glucose metabolism

Where it is running

• Ospedale Pediatrico Giovanni XXIII — Bari, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.